News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MAHAFFY PATRICK J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2022 |
4
| MAHAFFY PATRICK J (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 220,000 options to buy
@ $1.95, valued at
$429k
Granted 80,000 options to buy
@ $1.95, valued at
$156k
|
|
| 11/19/2021 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 39,824 shares
@ $8.5, valued at
$338.5k
Disposed/sold 18,000 options to buy
@ $17.61, valued at
$317k
Disposed/sold 18,000 options to buy
@ $21.85, valued at
$393.3k
Disposed/sold 18,000 options to buy
@ $13.83, valued at
$248.9k
Disposed/sold 18,000 options to buy
@ $20.16, valued at
$362.9k
Disposed/sold 18,000 options to buy
@ $28.14, valued at
$506.5k
Disposed/sold 18,000 options to buy
@ $11.74, valued at
$211.3k
Disposed/sold 12,500 options to buy
@ $11.88, valued at
$148.5k
Disposed/sold 12,500 options to buy
@ $9.22, valued at
$115.3k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 4,500 shares
@ $0
Granted 12,500 options to buy
@ $11.88, valued at
$148.5k
|
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 200,000 options to buy
@ $8.39, valued at
$1.7M
Granted 50,000 options to buy
@ $8.39, valued at
$419.5k
|
|
| 08/29/2019 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Exercised 30,824 options to buy
@ $0.16, valued at
$4.9k
|
|
| 08/19/2019 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Bought 400 shares
@ $5.56, valued at
$2.2k
Bought 400 shares
@ $5.58, valued at
$2.2k
Bought 3,706 shares
@ $5.57, valued at
$20.6k
Bought 2,100 shares
@ $5.61, valued at
$11.8k
Bought 6,400 shares
@ $5.61, valued at
$35.9k
Bought 11,314 shares
@ $5.58, valued at
$63.1k
Bought 3,700 shares
@ $5.59, valued at
$20.7k
Bought 11,053 shares
@ $5.59, valued at
$61.8k
Bought 5,100 shares
@ $5.6, valued at
$28.6k
Bought 5,827 shares
@ $5.6, valued at
$32.6k
|
|
| 06/21/2019 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 18,000 options to buy
@ $11.74, valued at
$211.3k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2018 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 18,000 options to buy
@ $28.14, valued at
$506.5k
|
|
| 03/02/2018 |
4
| MAHAFFY PATRICK J (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 120,000 options to buy
@ $58.43, valued at
$7M
|
|
| 07/27/2017 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 18,000 options to buy
@ $20.16, valued at
$362.9k
|
|
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2017 |
4
| MAHAFFY PATRICK J (See Remarks) has filed a Form 4 on Clovis Oncology, Inc. |
| 09/19/2016 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc. |
| 07/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2016 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 18,000 options to buy
@ $13.83, valued at
$248.9k
|
|
| 06/19/2015 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 18,000 options to buy
@ $21.85, valued at
$393.3k
|
|
| 06/10/2015 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.63, valued at
$231.5k
|
|
| 03/04/2015 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 100,000 options to buy
@ $79.05, valued at
$7.9M
|
|
| 06/27/2014 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.97, valued at
$298.5k
|
|
| 03/04/2014 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 18,000 options to buy
@ $17.61, valued at
$317k
|
|
| 01/14/2014 |
4
| MAHAFFY PATRICK J (See Remarks) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 200,000 options to buy
@ $73.98, valued at
$14.8M
|
|
| 06/07/2013 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $6.09, valued at
$213.2k
|
|
| 03/04/2013 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 200,000 options to buy
@ $21.81, valued at
$4.4M
|
|
| 06/11/2012 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $3.12, valued at
$109.2k
|
|
| 03/05/2012 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 150,000 options to buy
@ $24.74, valued at
$3.7M
|
|
| 11/21/2011 |
4
| MAHAFFY PATRICK J (President and CEO) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Converted 17,835 shares
@ $0
Converted 38,605 shares
@ $0
Converted 16,239 shares
@ $0
Bought 39,927 shares
@ $13, valued at
$519.1k
Converted 51,724 convertible preferred
@ $0
Converted 111,957 convertible preferred
@ $0
Converted convertible notes
@ $13, valued at
$0 |
|
| 06/06/2011 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.18, valued at
$63.6k
|
|
| 05/28/2010 |
4
| MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.52, valued at
$110.4k
|
|
| 05/29/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|